Estrogen receptor expression in benign breast epithelium and breast cancer risk

Journal of the National Cancer Institute

Volumn 90, Issue 1, 1998, Pages 37-42

  Khan, Seema A ^a   Rogers, Mary A M ^a   Khurana, Kamal K ^a   Meguid, Michael M ^a   Numann, Patricia J ^a  

^a SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR;

ARTICLE; BREAST CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PREMENOPAUSE; PROTEIN EXPRESSION; RECEPTOR DENSITY; RISK ASSESSMENT;

EID: 0032491774     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/90.1.37     Document Type: Article

References (21)

1. Cohen SM, Ellwein LB. Genetic errors, cell proliferation, and carcinogenesis. Cancer Res 1991;51:6493-505.
2. King RJ. William L. McGuire Memorial Symposium. Estrogen and progestin effects in human breast carcinogenesis. Breast Cancer Res Treat 1993;27:3-15.
3. Pike MC, Spicer DV, Dahmoush L, Press MF. Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk. Epidemiol Rev 1993;15:17-35.
4. Lemon HM, Heidel JW, Rodriguez-Sierra JF. Increased catechol estrogen metabolism as a risk factor for nonfamilial breast cancer. Cancer 1992;69:457-65.
5. Moore JW, Clark GM, Bulbrook RD, Hayward JL, Murai JT, Hammond GL, et al. Serum concentrations of total and non-protein-bound oestradiol in patients with breast cancer and in normal controls. Int J Cancer 1982;29:17-21.
6. Bernstein L, Ross RK. Endogenous hormones and breast cancer risk. Epidemiol Rev 1993; 15:48-65.
7. MacMahon B, Cole P, Brown J, Aoki K, Lin TM, Morgan RW, et al. Urine estrogen profiles of Asian and North American women. Int J Cancer 1974;14:161-7.
8. Katzenellenbogen BS, Bhardwaj B, Fang H, Ince BA, Pakdel F, Reese JC, et al. Hormone binding and transcription activation by estrogen receptors: analyses using mammalian and yeast systems. J Steroid Biochem Mol Biol 1993;47:39-48.
9. Dubik D, Dembinski TC, Shiu RP. Stimulation of c-myc oncogene expression associated with estrogen-induced proliferation of human breast cancer cells. Cancer Res 1987;47(24 Pt 1): 6517-21.
10. Katzenellenbogen BS, Nardulli A, Read L. Estrogen regulation of proliferation and hormonal modulation of estrogen and progesterone receptor biosynthesis and degradation in target cells. In: Molecular endocrinology of steroid hormone action. Proceedings of the Fourth International Symposium on Cellular Endocrinology. New York (NY): Alan R. Liss, 1990: 201-11.
11. Vanderbilt JN, Miesfeld R, Maler BA, Yamamoto KR. Intercellular receptor concentration limits glucocorticoid-dependent enhancer activity. Mol Endocrinol 1987;1:68-74.
12. Webb P, Lopez GN, Greene GL, Baxter JD, Kushner PJ. The limits of the cellular capacity to mediate an estrogen response. Mol Endocrinol 1992;6:157-67.
13. Khan SA, Rogers MA, Obando JA, Tamsen A. Estrogen receptor expression of benign breast epithelium and its association with breast cancer. Cancer Res 1994;54:993-7.
14. el-Badawy N, Cohen C, DeRose PB, Sgoutas D. Immunohistochemical estrogen receptor assay: quantitation by Image Analysis. Mod Pathol 1991;4:305-9.
15. Breslow NE, Day NE. Statistical methods in cancer research. Volume I: The analysis of case control studies. IARC Sci Publ 1980;(32): 5-338.
16. Battersby S, Robertson BJ, Anderson TJ, King RJB, McPherson K. Influence of menstrual cycle, parity and oral contraceptive use on steroid hormone receptors in normal breast. Br J Cancer 1992;4:601-7.
17. Williams G, Anderson E, Howell A, Watson R, Coyne J, Roberts SA, et al. Oral contraceptives (OCP) use increases proliferation and decreases oestrogen receptor content of epithelial cells in the normal human breast. Int J Cancer 1991;48:206-10.
18. Markopoulos C, Berger U, Wilson P, Gazet JC, Coombes RC. Oestrogen receptor content of normal breast cells and breast carcinomas throughout the menstrual cycle. Br Med J 1988;296:1349-51.
19. Soderqvist G, von Schoultz B, Tani E, Skoog L. Estrogen and progesterone receptor content in breast epithelial cells from healthy women during the menstrual cycle. Am J Obstet Gynecol 1993;168(3 Pt 1):874-9.
20. Hislop TG, Elwood JM, Coldman AJ, Spinelli JJ, Worth AJ, Ellison LG. Second primary cancers of the breast: incidence and risk factors. Br J Cancer 1984;49:79-85.
21. Khan SA. Estrogen and progesterone receptors in benign breast epithelium. The Breast Journal 1995;1:251-61.